41 Confronting Drug-Resistant Tuberculosis Head On

Friday, March 19, 2010: 2:00 PM-3:30 PM
International North-South (Hyatt Regency Atlanta)
CME Credits: 1.50
Type: Oral
Summary: Patients with drug-resistant TB, particularly XDR-TB, are left with treatment options that are much less effective and often have worse clinical outcomes. This session will review the global epidemiology of drug-resistant TB, existing data on drug-resistant TB, including XDR-TB, outbreaks associated with healthcare facilities, and infection control techniques, including novel methods, for reducing nosocomial transmission of drug-resistant TB.
Learning Objectives:
Co-Organized by:
the International Federation of Infection Control (IFIC)
Anucha Apisarnthanarak, MD and Kent Sepkowitz
2:00 PM
The Global Epidemiology of XDR-TB in 2010: Challenges, Morbidity, and Anticipated Burden
J. Peter Cegielski, MD, MPH, Centers for Disease Control and Prevention
2:30 PM
XDR-TB Outbreaks in Healthcare Settings
Neel Gandhi, MD, Albert Einstein College of Medicine
3:00 PM
Infection Control Issues Specific to XDR-TB
Henry Blumberg, MD, Emory University School of Medicine